ビスフォスフォネート製剤休薬による尿中 I 型コラーゲン架橋 C-テロペプタイド値の変動について

  • 岩本 修
    久留米大学医学部歯科口腔医療センター
  • 岩屋 勝美
    久留米大学医学部歯科口腔医療センター
  • 轟 圭太
    久留米大学医学部歯科口腔医療センター
  • 古場 朗洋
    久留米大学医学部歯科口腔医療センター
  • 古賀 真
    久留米大学医学部歯科口腔医療センター
  • 楠川 仁悟
    久留米大学医学部歯科口腔医療センター

書誌事項

タイトル別名
  • Fluctuation of the type I collagen cross-linked C-telopeptide value in urine after withdrawal of bisphosphonates
  • ビスフォスフォネート セイザイキュウヤク ニ ヨル ニョウチュウ Iガタ コラーゲン カケハシ C-テロペプタイドチ ノ ヘンドウ ニ ツイテ

この論文をさがす

説明

We previously reported that the measurement of type I collagen cross-linked C-telopeptide in urine (u-CTX) is useful for evaluating the risk of developing bisphosphonate (BP) -related osteonecrosis of the jaw (BRONJ). In this study, we observed fluctuations of the u-CTX value after the withdrawal of BP.<br>The subjects were 84 patients who were using BP in whom the withdrawal of BP for 3 months was possible. The u-CTX value is expressed as the interquartile range (median [25% point, 75% point]. The u-CTX value before withdrawal was 59.5 [36.0, 99.8] Cr value, and increased to 110.0 [69.3, 161.5] Cr value 3 months after withdrawal (p<0.001). Although we previously presented the cutoff value (98 Cr value) of u-CTX as related to the risk of developing BRONJ, the u-CTX value in this study was lower than the 98 Cr value before withdrawal, and increased to a level higher than the 98 Cr value after withdrawal for 3 months in 35 (56.5%) of 62 patients in the oral administration group, as compared with only 1 (11%) of 9 patients in the injection administration group. Furthermore, this was noted in 19 (47%) of 40 patients in the steroid non-combined use group and only 6 (27%) of 22 patients in the combined use group. Forty-one patients with a u-CTX value of higher than 98 Cr did not develop BRONJ after an extraction. Of the 9 patients with a u-CTX value of less than 98 Cr, 3 developed BRONJ after an extraction.<br>These results suggest that improvement in the bone metabolic capacity, which was being suppressed by BP, can be detected by measuring the u-CTX value after the withdrawal of BP, and this value might be a useful index to judge the appropriate time for tooth extraction. However, it should be noted that the u-CTX values in patients who received BP injections or the combined use of steroids were low before withdrawal and did not readily increase even after withdrawal.

収録刊行物

参考文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ